The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing
2025 · BMC Cancer · 0 citations
https://doi.org/10.1186/s12885-025-14968-2